Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience

Anup Kasi, Timothy McGinnis, Gurudatta Naik, Shivani Handa, Grant Williams, Ravi Paluri